Finch Therapeutics Group, Inc. — Form D/A
Finch Therapeutics Group, Inc. of SOMERVILLE, MA, a company, filed a Form D amendment with the SEC on 2019-07-19. The offering totals $53.5M, of which $53.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-07-19
- Form: D/A
- Accession: 0001733257-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $53.5M
- Amount sold: $53.5M
- Investors: 22
- Date of first sale: 2019-05-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-339914
Issuer
- Name: Finch Therapeutics Group, Inc.
- CIK: 0001733257
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 200 INNER BELT ROAD, SOMERVILLE, MA, 02143
- Phone: 617-229-6499
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Alan A Gross | Director | Somerville, MA |
| Greg A Perry | Executive Officer | Somerville, MA |
| Ulrich A Thienel | Executive Officer | Somerville, MA |
| Mark Smith | Director | Palo Alto, CA |
| Mark Smith | Executive Officer | Palo Alto, CA |
| James Burgess | Director | Provo, UT |
| James Burgess | Executive Officer | Provo, UT |
| Domenic Ferrante | Director | NAPLES, FL |
| Jo A Viney | Director | Somerville, MA |
| Zain Kassam | Executive Officer | Somerville, MA |
| Jeffery A Smisek | Director | Somervlle, MA |
| Christopher A Cosmides | Director | Somerville, MA |
| Benjamin Enerson | Executive Officer | Somerville, MA |
| Andrew Mulderry | Director | Somerville, MA |
| Andrew Noh | Director | Somerville, MA |
| Andrew Noh | Executive Officer | Somerville, MA |
| Chris Lange | Director | Somerville, MA |
| R. J Price | Director | Somerville, MA |
Other filings by this issuer (4)
More